Search alternatives:
significantly reported » significantly related (Expand Search), significantly restored (Expand Search), significantly predicted (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
gap decrease » a decrease (Expand Search), gain decreased (Expand Search), mean decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
Showing 1 - 20 results of 7,502 for search '(( significant ((gap decrease) OR (we decrease)) ) OR ( significantly reported decrease ))', query time: 0.63s Refine Results
  1. 1
    Overview of the WeARTolerance program.

    Overview of the WeARTolerance program. by Ana Beato (20489933)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 2
    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  3. 3
    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  4. 4
    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  5. 5
    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  6. 6
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  7. 7
    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  8. 8
    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  9. 9
    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  10. 10
    iKIR score decreases protection associated with protective class II genotypes in T1D.

    iKIR score decreases protection associated with protective class II genotypes in T1D. by Laura Mora-Bitria (20477525)

    Published 2024
    Save to List
    Saved in:
  11. 11
    S8 File -

    S8 File - by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 12
    Study populations of included studies.

    Study populations of included studies. by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 13
    Future research directions.

    Future research directions. by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 14
    PRISMA flow diagram.

    PRISMA flow diagram. by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 15
    S9 File -

    S9 File - by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 16
    S7 File -

    S7 File - by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 17
    Participant characteristics of included studies.

    Participant characteristics of included studies. by Martha R. Smith (20410184)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 18
    This is the data set that we used to reach the conclusions drawn in the manuscript with related metadata and methods.

    This is the data set that we used to reach the conclusions drawn in the manuscript with related metadata and methods. by Farayi Kaseke (19560197)

    Published 2024
    Save to List
    Saved in:
  19. 19
    BMI groups by SES.

    BMI groups by SES. by Krystal Hunter (6820052)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    BMISES_Data_Part2.

    BMISES_Data_Part2. by Krystal Hunter (6820052)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: